BCYC
Price
$21.82
Change
-$0.11 (-0.50%)
Updated
Apr 17, 6:59 PM EST
14 days until earnings call
INSM
Price
$26.30
Change
+$0.12 (+0.46%)
Updated
Apr 18, 10:24 AM EST
14 days until earnings call
Ad is loading...

BCYC vs INSM ᐉ Comparison: Which is Better to Invest?

Header iconBCYC vs INSM Comparison
Open Charts BCYC vs INSMBanner chart's image
Bicycle Therapeutics
Price$21.82
Change-$0.11 (-0.50%)
Volume$327.45K
CapitalizationN/A
Insmed
Price$26.30
Change+$0.12 (+0.46%)
Volume$100
CapitalizationN/A
View a ticker or compare two or three
BCYC vs INSM Comparison Chart

Loading...

BCYCDaily Signal changed days agoGain/Loss if shorted
 
Show more...
INSMDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
BCYC vs. INSM commentary
Apr 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCYC is a Hold and INSM is a StrongSell.

COMPARISON
Comparison
Apr 18, 2024
Stock price -- (BCYC: $21.82 vs. INSM: $26.18)
Brand notoriety: BCYC and INSM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCYC: 174% vs. INSM: 72%
Market capitalization -- BCYC: $828.45M vs. INSM: $3.89B
BCYC [@Biotechnology] is valued at $828.45M. INSM’s [@Biotechnology] market capitalization is $3.89B. The market cap for tickers in the [@Biotechnology] industry ranges from $551.2B to $0. The average market capitalization across the [@Biotechnology] industry is $2.51B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCYC’s FA Score shows that 0 FA rating(s) are green whileINSM’s FA Score has 0 green FA rating(s).

  • BCYC’s FA Score: 0 green, 5 red.
  • INSM’s FA Score: 0 green, 5 red.
According to our system of comparison, BCYC is a better buy in the long-term than INSM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCYC’s TA Score shows that 4 TA indicator(s) are bullish while INSM’s TA Score has 3 bullish TA indicator(s).

  • BCYC’s TA Score: 4 bullish, 5 bearish.
  • INSM’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, BCYC is a better buy in the short-term than INSM.

Price Growth

BCYC (@Biotechnology) experienced а -5.09% price change this week, while INSM (@Biotechnology) price change was -7.78% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.68%. For the same industry, the average monthly price growth was -1.35%, and the average quarterly price growth was +1229.70%.

Reported Earning Dates

BCYC is expected to report earnings on Aug 01, 2024.

INSM is expected to report earnings on Aug 01, 2024.

Industries' Descriptions

@Biotechnology (-6.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for BCYC with price predictions.
OPEN
A.I.dvisor published
a Summary for INSM with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
INSM($3.89B) has a higher market cap than BCYC($828M). BCYC YTD gains are higher at: 20.686 vs. INSM (-15.521).
BCYCINSMBCYC / INSM
Capitalization828M3.89B21%
EBITDAN/AN/A-
Gain YTD20.686-15.521-133%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
INSM: Fundamental Ratings
INSM
OUTLOOK RATING
1..100
63
VALUATION
overvalued / fair valued / undervalued
1..100
82
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
50
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BCYCINSM
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
75%
Momentum
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
67%
MACD
ODDS (%)
N/A
Bearish Trend 1 day ago
68%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
72%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
74%
Advances
ODDS (%)
Bullish Trend 22 days ago
87%
Bullish Trend 23 days ago
71%
Declines
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 3 days ago
74%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
75%
Aroon
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
82%
View a ticker or compare two or three
Ad is loading...
BCYCDaily Signal changed days agoGain/Loss if shorted
 
Show more...
INSMDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
RFCI21.880.07
+0.34%
RiverFront Dynamic Core Income ETF
KBND31.39N/A
N/A
KraneShares Bloomberg China
BKHY46.43-0.02
-0.04%
BNY Mellon High Yield Beta ETF
OSEA26.25-0.02
-0.07%
Harbor International Compounders ETF
QQQE83.97-0.96
-1.13%
Direxion NASDAQ-100® Equal Wtd ETF

BCYC and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCYC has been loosely correlated with PHIO. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if BCYC jumps, then PHIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCYC
1D Price
Change %
BCYC100%
-0.50%
PHIO - BCYC
41%
Loosely correlated
-0.79%
MLTX - BCYC
39%
Loosely correlated
+0.02%
ORMP - BCYC
35%
Loosely correlated
-2.92%
SAGE - BCYC
34%
Loosely correlated
-19.58%
AXON - BCYC
34%
Loosely correlated
-0.16%
More

INSM and

Correlation & Price change

A.I.dvisor indicates that over the last year, INSM has been loosely correlated with SRPT. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if INSM jumps, then SRPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INSM
1D Price
Change %
INSM100%
+0.11%
SRPT - INSM
44%
Loosely correlated
+0.51%
RARE - INSM
42%
Loosely correlated
+4.25%
MNKD - INSM
41%
Loosely correlated
+1.23%
VERA - INSM
41%
Loosely correlated
-6.01%
AXON - INSM
40%
Loosely correlated
-0.16%
More